Journal of Clinical Psychopharmacology

Top Research Topics at Journal of Clinical Psychopharmacology?

The journal covers a variety of subjects, including Internal medicine, Psychiatry, Anesthesia, Pharmacology and Placebo. Topics in Internal medicine explored in it were investigated in conjunction with research in Endocrinology, Clozapine, Gastroenterology, Olanzapine and Antipsychotic. Issues in Psychiatry were discussed, taking into consideration concepts from other disciplines like Clinical psychology and MEDLINE.

Many of the studies tackled connect MEDLINE with a similar field of study like Text mining. The journal focuses on Anesthesia research which is adjacent to topics in Adverse effect. Pharmacokinetics is the primary subject of Pharmacology works presented in the journal.

The presented research on Placebo deals specifically with Randomized controlled trial but it also addresses topics in Clinical trial. The Schizophrenia study tackling the subject of Risperidone is the focus of it. The works on Depression (differential diagnoses) deal in particular with Antidepressant.

• Internal medicine (28.32%)
• Psychiatry (27.19%)
• Anesthesia (19.10%)

What are the most cited papers published in the journal?

• Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. (1073 citations)
• A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. (735 citations)
• Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. (618 citations)

Research areas of the most cited articles at Journal of Clinical Psychopharmacology:

The most cited papers primarily tackle Internal medicine, Psychiatry, Anesthesia, Placebo and Randomized controlled trial. While Internal medicine is the focus of the journal papers, it also provides insights into the studies of Endocrinology and Schizophrenia, Olanzapine, Antipsychotic. Psychiatry study tackled in the journal publications is connected to the field of Clinical psychology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Diabetes mellitus

The previous edition focused in particular on these issues:

The journal explores disciplines such as Internal medicine, MEDLINE, Schizophrenia, Pediatrics and Psychiatry. Placebo, Clozapine and Depression (differential diagnoses) are some topics wherein Internal medicine research discussed in it have an impact. Journal of Clinical Psychopharmacology addresses concerns in Depression (differential diagnoses) which are intertwined with other disciplines, such as Anesthesia and Clinical trial.

MEDLINE research presented in Journal of Clinical Psychopharmacology encompasses a variety of subjects, including Text mining and Intensive care medicine. Bipolar disorder is a focus of the Psychiatry works in Journal of Clinical Psychopharmacology. The journal focuses on Randomized controlled trial but the discussions also offer insight into other areas such as Antidepressant, Cognition and Anxiety.

The most cited articles from the last journal are:

• A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder. (6 citations)
• Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults. (4 citations)
• Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Journal of Clinical Psychopharmacology (based on the number of publications) are:

• Richard I. Shader (235 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• David J. Greenblatt (168 papers) absent at the last edition,
• David L. Streiner (48 papers) absent at the last edition,
• Karl Rickels (43 papers) absent at the last edition,
• Edward M. Sellers (42 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Clinical Psychopharmacology (based on the number of publications) are:

• Harvard University (150 papers) published 3 papers at the last edition the same number as at the previous edition,
• University of Toronto (85 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• Tufts University (78 papers) published 4 papers at the last edition, 4 less than at the previous edition,
• University of Pittsburgh (74 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Columbia University (63 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 25.90% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.20% were posted by at least one author from the top 10 institutions publishing in the journal. Another 3.25% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 12.20% of all publications and 72.36% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Licensure Requirements in the Field of Psychology

Another crucial aspect to delve into is the exploration of career opportunities in the related field. Whether you are thinking about transitioning into a profession in psychology or you're already in the field looking to advance, it’s important to be informed about the prospects. In the U.S, psychology-based professions are projected to grow significantly over the next decade, providing a range of opportunities for individuals with relevant qualifications. In this regard, for those considering a career in psychology within Vermont, the state has a set of defined licensure requirements that need to be fulfilled. Understanding these requirements can assist aspiring professionals in proceeding confidently and informedly towards their career goals. To become a psychologist in Vermont, you’ll need to meet several pre-licensure requirements. All the necessary steps including education prerequisite, examination, and supervised practice requirements are detailed in comprehensive manner our article on psychologist education requirements in vermont. Knowing these vital details can help you map your career path in the field effectively and efficiently. Despite the challenges, careers in psychology are rewarding. Considering the findings and topics discussed in the Journal of Clinical Psychopharmacology can pave the way to diverse career specialties such as becoming a clinical, research, or counseling psychologist. Armed with your skills and knowledge, you will be well-prepared to make significant contributions to this continually evolving field.